3 Things About Moderna That Smart Investors Know
By now everyone knows that Moderna(NASDAQ:MRNA) was instrumental in the fight against COVID-19. Its vaccine — mRNA-1273 — was authorized only a week after Pfizer’s (NYSE:PFE) in November 2020. In the eight months since, revenue and profits have poured…
